Navigation Links
TANDEM DIABETES CARE BECOMES PRESENTING SPONSOR OF THE GREATEST AWARDS SHOW IN DIABETES
Date:8/8/2013

SAN DIEGO, Aug. 8, 2013 /PRNewswire-iReach/ -- Insulindependence (IN) announced today that Tandem Diabetes Care, manufacturer of the t:slim® Insulin Pump, has become the Presenting Sponsor of The Greatest Awards Show in Diabetes. The event will be hosted at the House of Blues in San Diego, August 17, 2013, as the red carpet highlight of IN's 2013 North American Conference on Diabetes and Exercise. This year's show will bring together some of the biggest names in diabetes to recognize the year's most notable achievements in diabetes and sport.

Masters of Ceremonies are diabetes patient blogger Kerri Morrone Sparling and Mt. Everest Climber and Ironman Triathlete Sebastien Sasseville.

Insulindependence and Tandem Diabetes Care will honor eight individuals, including this year's winner of the Paula and Lew Harper Collegiate Scholarship ($1,000) and Grand Prize Athletic Achievement Award ($5,000). The public is invited to vote on nominees via the Insulindependence website through August 15, 2013.

"It's a unique privilege to work with a local partner on an international scale," said Peter Nerothin, Founder and President of Insulindependence. "Tandem brings an electrifying energy that's a perfect match for our overarching goal of empowerment."

"The diabetes community never ceases to inspire us, and this program is a perfect example of the reasons why," said Kim Blickenstaff, president and CEO of Tandem Diabetes Care. "We are proud to be a supporter of Insulindependence and the active diabetes community, and we look forward to a great event."

Tickets for The Greatest Awards Show in Diabetes are for sale online for purchase by the public: http://www.insulindependence.org/in-conference/athletic-achievement-award/attend-the-show/

About Insulindependence |

Insulindependence (IN) (www.insulindependence.org) is a nonprofit member association dedicated to uniting, expanding, and supporting the active diabetes community. With support from over 4,000 individual members, 8,000 donors and a growing number of member organizations, we are a leading authority in exercise and recreation for people living with diabetes. Through excellence in member services, outreach, and education we are actively pursuing our vision to reduce the burden of diabetes in the United States through physical activity and peer support.

About Tandem Diabetes Care |

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a privately held company dedicated to advancing the management of diabetes through novel technologies. The Company offers a comprehensive, user-centric and integrated approach to product design, development, and customer care. Tandem Diabetes Care is based in San Diego, Calif.

Media Contact: Blair Ryan, Insulindependence, Inc., 888.912.3837 Ext. 108, Blair@insulindependence.org

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Insulindependence, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tandem Diabetes Care Acquires Select Patents and Patent Applications from Smiths Medical
2. Data Related to Chimerixs Antiviral CMX001 to be Presented in Three Poster Sessions at the BMT Tandem Meetings
3. Data Demonstrating the Safety and Efficacy of Chimerixs Antiviral CMX001 Presented at BMT Tandem Meetings
4. Tandem Diabetes Care Names Lonnie Smith As Chairman Of The Board
5. Tandem Diabetes Care Announces FDA Clearance of t:connect Diabetes Management Application for Use with t:slim Insulin Pump
6. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
7. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
8. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
9. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
10. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
11. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/8/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., has completed ... a health care service center company based in ... in relationship management programs for leading pharmaceutical manufacturers and ... WRB will join Envoy Health Management, LLC ... manufacturers, biotech firms, and other service companies. Together, WRB ...
(Date:5/4/2017)... -- Fortuna Fix Inc. (" Fortuna "), a private, clinical-stage ... the need for embryonic and fetal stem cells by using ... Fortuna announced today the launch of its ... MD, PhD; Father Kevin FitzGerald , S.J., PhD; Col. ... James Giordano , PhD. "We are excited and ...
(Date:5/4/2017)... 4, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading ... data solutions, today announced that it is teaming up ... Technologies Limited to lower diabetes healthcare costs in ... card, which is available throughout all provinces and territories ... be eligible for additional savings when shopping for Dario ...
Breaking Medicine Technology:
(Date:5/28/2017)... ... ... Viewers likely know Rob Lowe from such 80s hits as St. Elmo’s Fire and ... The West Wing and Parks and Recreation. But recently, Lowe’s leant his talents to ... on important modern-day issues that face today’s society. One of the most recent episodes ...
(Date:5/27/2017)... ... May 27, 2017 , ... Most us are familiar with the sound of ... from the Osteoarthritis Initiative shows that certain people who experience consistent joint popping, ... may give doctors the opportunity to treat patients before the problem becomes pronounced, potentially ...
(Date:5/26/2017)... ... 2017 , ... Amir Qureshi, MD is the first physician in Arkansas to ... system. The Nuvectra™ Algovita SCS System has been FDA approved as a treatment option ... Arkansas to introduce the most powerful SCS system and the only stretchable lead on ...
(Date:5/26/2017)... , ... May 26, 2017 , ... On May 24, ... which narrowly passed the U.S. House on May 4, would result in 23 million ... under continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral ... new, informational blog post on insurance options. If a Bay Area patient has to ... save time and money. Visiting an in-network provider for a second opinion can ensure ...
Breaking Medicine News(10 mins):